1. Case Report: Targeted Therapy with Anlotinib for a Rare Case of Spinal Cord Glioblastoma with FGFR3 Mutation
   Ruiqiong Liu et al, 2022, OncoTargets and Therapy CrossRef
2. Mutation S249C of FGFR3b Promotes Bladder Cancer through Downstream Signaling Proteins FRS2 and FRS3: A Computational Approach
   Aisha Ali et al, 2023, Current Signal Transduction Therapy CrossRef